Sarcopenic obesity: what about in the cancer setting?
Growing evidence suggests that changes in muscle mass and function may further
contribute to health risk assessment in individuals who are obese. As numbers for both …
contribute to health risk assessment in individuals who are obese. As numbers for both …
Prognostic Role of" Radiological" Sarcopenia in Lymphoma: A Systematic Review
Sarcopenia is considered to be a poor prognostic factor for several oncological diseases;
however, some promising results for lymphoma are now available. The definition of …
however, some promising results for lymphoma are now available. The definition of …
Comparison between skeletal muscle and adipose tissue measurements with high-dose CT and low-dose attenuation correction CT of 18F-FDG PET/CT in elderly …
Objectives: High-dose CT (HDCT) is considered the gold-standard imaging for the
measurements of skeletal muscle area (SMA), visceral adipose tissue (VAT), subcutaneous …
measurements of skeletal muscle area (SMA), visceral adipose tissue (VAT), subcutaneous …
Prognostic impact of muscle quantity and quality and fat distribution in diffuse large B-cell lymphoma patients
G Besutti, F Massaro, E Bonelli, L Braglia… - Frontiers in …, 2021 - frontiersin.org
Baseline CT scans of 116 patients (48% female, median 64 years) with diffuse large B-cell
lymphoma (DLBCL) were retrospectively reviewed to investigate the prognostic role of …
lymphoma (DLBCL) were retrospectively reviewed to investigate the prognostic role of …
Sarcopenia and low muscle radiodensity associate with impaired FEV1 in allogeneic haematopoietic stem cell transplant recipients
A Mishra, KD Bigam, M Extermann… - Journal of cachexia …, 2020 - Wiley Online Library
Background Quantification of skeletal muscle using computed tomography (CT) is
accessible using cancer patients' standard oncologic images. Reduced muscle mass may …
accessible using cancer patients' standard oncologic images. Reduced muscle mass may …
Longitudinal Body Composition Changes Detected by [18F]FDG PET/CT during and after Chemotherapy and Their Prognostic Role in Elderly Hodgkin Lymphoma
Simple Summary The effective role of sarcopenia and body changes during treatment in
elderly (> 65 years) Hodgkin lymphoma (HL) is unclear. The aim of our study was to analyze …
elderly (> 65 years) Hodgkin lymphoma (HL) is unclear. The aim of our study was to analyze …
Deep-learning assessed muscular hypodensity independently predicts mortality in DLBCL patients younger than 60 years
M Jullien, B Tessoulin, H Ghesquières, L Oberic… - Cancers, 2021 - mdpi.com
Simple Summary Cachexia is a major cause of mortality in cancer patients and is
characterized by a continuous skeletal muscle loss. Muscle depletion assessed by …
characterized by a continuous skeletal muscle loss. Muscle depletion assessed by …
Sarcopenia screening allows identifying high-risk patients for allogenic stem cell transplantation
J Kirsten, V Wais, SVW Schulz, E Sala, G Treff… - Cancers, 2021 - mdpi.com
Simple Summary Allogenic stem cell transplantation is a treatment option for various
hematological diseases. Due to the intensity of the therapy regimes used, there is a …
hematological diseases. Due to the intensity of the therapy regimes used, there is a …
Impact of obesity and visceral fat on mortality in hematopoietic stem cell transplantation
AZ Pereira, B de Almeida‐Pitito… - Journal of Parenteral …, 2021 - Wiley Online Library
Rationale: Many studies have shown the importance of body composition parameters,
muscle, and fat mass, evaluated by several methods in hematopoietic stem cell …
muscle, and fat mass, evaluated by several methods in hematopoietic stem cell …
Body composition after allogeneic haematopoietic cell transplantation/total body irradiation in children and young people: a restricted systematic review
A Lorenc, J Hamilton-Shield, R Perry… - Journal of Cancer …, 2020 - Springer
Purpose To collate evidence of changes in body composition following treatment of
leukaemia in children, teenagers and young adults (CTYA, 0–24 years) with allogeneic …
leukaemia in children, teenagers and young adults (CTYA, 0–24 years) with allogeneic …